Simplifying Patient Experience, Empowering Providers

“Cellular-enabled SANSA paves the way for sleep physicians and technicians to receive data in near real-time once a test is complete, enabling more efficient workflows and accelerating time to care. Simultaneously, it eliminates a common practical headache for patients: the need to download a phone app and pair devices over Bluetooth,” said Brennan Torstrick, Huxley President and Chief Scientific Officer. “This clearance is an important milestone to expand access to home sleep testing and adds another differentiating feature to SANSA. We are proud to offer the only hands-free, wire-free, and app-free test solution.”

Proven Clinical Accuracy

SANSA’s initial FDA clearance in 2024 validated accuracy against gold-standard polysomnography in a 340-patient clinical trial conducted at seven institutions. The test uniquely combines nine physiological channels—including oximetry, respiratory effort, sleep/wake staging, and a reference electrocardiogram (ECG)—into a single chest-worn patch, enabling expanded insights into cardiopulmonary health